Why Tracking Matters: The response to GLP-1 medications can vary from person to person
MAPP investigators performed a 1-year observational cohort study of over 200 women with IC/BPS and identified important clinical factors associated with quality-of-life outcomes and with symptom trajectories over time, including the presence of pain outside the pelvis, the presence of concurrent nonurological chronic pain conditions (such as fibromyalgia and irritable bowel syndrome), and the severity of bladder-focused symptoms (
Figure 2 illustrates several primary routes across the BBB: positively charged macromolecules cross the BBB via adsorptive-mediated transcytosis (AMT)
Mulvihill and Drucker, 2014)
Return of Appetite Once retatrutide is stopped, appetite signaling returns
We have previously reported increased thalamic vascularity in painful diabetic peripheral neuropathy (PDPN) but the microvascular perfusion of the other pain processing areas of the brain (Pain Matrix - PM), with or without pain at the time of scanning, is unknown